These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 1651526

  • 21. Primary and Recurrent Growing Teratoma Syndrome in Central Nervous System Nongerminomatous Germ Cell Tumors: Case Series and Review of the Literature.
    Tsuyuguchi S, Sugiyama K, Kinoshita Y, Kolakshyapati M, Takayasu T, Usui S, Takano M, Yonezawa U, Taguchi A, Amatya VJ, Takeshima Y, Kurisu K, Yamasaki F.
    World Neurosurg; 2020 Feb; 134():e360-e371. PubMed ID: 31751614
    [Abstract] [Full Text] [Related]

  • 22. [Observation policy for residual masses after chemotherapy for gonadal and extra-gonadal germ cell tumors].
    Takizawa A, Miura T, Fujinami K, Osada Y.
    Hinyokika Kiyo; 2005 Apr; 51(4):247-51. PubMed ID: 15912783
    [Abstract] [Full Text] [Related]

  • 23. The growing teratoma syndrome: an unusual manifestation of treated, nonseminomatous germ cell tumors of the testis.
    Lorigan JG, Eftekhari F, David CL, Shirkhoda A.
    AJR Am J Roentgenol; 1988 Aug; 151(2):325-9. PubMed ID: 2839969
    [Abstract] [Full Text] [Related]

  • 24. Predictors of residual mass histology after chemotherapy for advanced testis cancer.
    Sagalowsky AI, Ewalt DH, Molberg K, Peters PC.
    Urology; 1990 Jun; 35(6):537-42. PubMed ID: 2162091
    [Abstract] [Full Text] [Related]

  • 25. Pathologic findings at orchiectomy following chemotherapy for disseminated testicular cancer.
    Greist A, Einhorn LH, Williams SD, Donohue JP, Rowland RG.
    J Clin Oncol; 1984 Sep; 2(9):1025-7. PubMed ID: 6088708
    [Abstract] [Full Text] [Related]

  • 26. Contemporary management of postchemotherapy testis cancer.
    Daneshmand S, Albers P, Fosså SD, Heidenreich A, Kollmannsberger C, Krege S, Nichols C, Oldenburg J, Wood L.
    Eur Urol; 2012 Nov; 62(5):867-76. PubMed ID: 22938868
    [Abstract] [Full Text] [Related]

  • 27. [Differentiated teratoma as late recurrence of metastatic non-seminomatous testicular germ cell tumor. Case report and clinical problems].
    Kuczyk MA, Bokemeyer C, Fichna B, Truss M, Schmoll HJ, Jonas U.
    Urologe A; 1995 Nov; 34(6):480-4. PubMed ID: 8848861
    [Abstract] [Full Text] [Related]

  • 28. Excision of residual masses after platinum based chemotherapy for non-seminomatous germ cell tumours.
    Harding MJ, Brown IL, MacPherson SG, Turner MA, Kaye SB.
    Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1689-94. PubMed ID: 2561098
    [Abstract] [Full Text] [Related]

  • 29. Retroperitoneal metastases in testicular cancer: role of CT measurements of residual masses in decision making for resection after chemotherapy.
    Steyerberg EW, Keizer HJ, Sleijfer DT, Fossâ SD, Bajorin DF, Gerl A, de Wit R, Kirkels WJ, Koops HS, Habbema JD.
    Radiology; 2000 May; 215(2):437-44. PubMed ID: 10796922
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. CT of primary germ-cell tumors of the mediastinum.
    Levitt RG, Husband JE, Glazer HS.
    AJR Am J Roentgenol; 1984 Jan; 142(1):73-8. PubMed ID: 6318540
    [Abstract] [Full Text] [Related]

  • 32. Residual pulmonary masses after chemotherapy for metastatic nonseminomatous germ cell tumor. Prediction of histology. ReHiT Study Group.
    Steyerberg EW, Keizer HJ, Messemer JE, Toner GC, Schraffordt Koops H, Fosså SD, Gerl A, Sleijfer DT, Donohue JP, Habbema JD.
    Cancer; 1997 Jan 15; 79(2):345-55. PubMed ID: 9010108
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Post-chemotherapy surgery in advanced non-seminomatous germ-cell testicular tumours: the significance of histology with particular reference to differentiated (mature) teratoma.
    Tait D, Peckham MJ, Hendry WF, Goldstraw P.
    Br J Cancer; 1984 Nov 15; 50(5):601-9. PubMed ID: 6093838
    [Abstract] [Full Text] [Related]

  • 38. Primary mediastinal malignant germ cell neoplasms: imaging features.
    Strollo DC, Rosado-de-Christenson ML.
    Chest Surg Clin N Am; 2002 Nov 15; 12(4):645-58. PubMed ID: 12471868
    [Abstract] [Full Text] [Related]

  • 39. Clinical outcomes and histological findings of patients with advanced metastatic germ cell tumors undergoing post-chemotherapy resection of retroperitoneal lymph nodes and residual extraretroperitoneal masses.
    Nakamura T, Oishi M, Ueda T, Fujihara A, Nakanishi H, Kamoi K, Naya Y, Hongo F, Okihara K, Miki T.
    Int J Urol; 2015 Jul 15; 22(7):663-8. PubMed ID: 25847721
    [Abstract] [Full Text] [Related]

  • 40. Clinical outcomes of patients with nonseminomatous germ cell tumours and negative postchemotherapy positron emission tomography.
    Buchler T, Simonova K, Fencl P, Jarkovsky J, Abrahamova J.
    Cancer Invest; 2012 Jul 15; 30(6):487-92. PubMed ID: 22506657
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.